Ignite Creation Date:
2024-05-05 @ 5:08 PM
Last Modification Date:
2024-10-26 @ 9:28 AM
Study NCT ID:
NCT00398060
Status:
COMPLETED
Last Update Posted:
2008-02-14
First Post:
2006-11-09
Brief Title:
GOAL Life-Style Change Intervention to Prevent Type 2 Diabetes
Sponsor:
Finnish Institute for Health and Welfare
Organization:
Finnish Institute for Health and Welfare
Study Overview
Official Title:
GOAL Life-Style Change Implementation Intervention to Prevent Type 2 Diabetes in Primary Health Care
Status:
COMPLETED
Status Verified Date:
2008-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Life-style change achieved in controlled experimental condition has been shown to prevent type 2 diabetes The purpose of this study is to evaluate to what extent the life-style change can be achieved in a routine health care setting
Detailed Description:
The GOAL Good Ageing in Lahti region Program Life-style change implementation trial to prevent type 2 diabetes was set to examine and enhance the effectiveness of life-style change counselling in the primary health care In the intervention specific nutritional physical activity and weight loss objectives shown effective in diabetes prevention in an earlier randomised controlled trial are used as a benchmark embedded in a structured group counselling model with an empowerment-oriented approach and adapted into the primary health care setting In the trial effectiveness and process are evaluated the analyses including gender and socio-economic differences Participants were 361 middle-aged 50-65 yrs adults at an increased risk for type 2 diabetes recruited in 16 primary health care centres in Paijat-Hame Finland Intervention and data collection took place in year 2003
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None